Comparable stake leader
EverSource Wealth Advisors, LLC
SEC ownership of Anbio Biotechnology
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001982708.
Disclosed value leader
EverSource Wealth Advisors, LLC
Comparable rows
0/2
Latest evidence
30 Jun 2026
- Public ticker
- NNNN on Nasdaq
- Parsed ownership sources
-
13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
EverSource Wealth Advisors, LLC
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001982708
- Issuer location
- Frankfurt Am Main, Germany
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Anbio Biotechnology (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EverSource Wealth Advisor...
Disclosed value leader
EverSource Wealth Advisor...
Comparable rows
0/2
Latest evidence
30 Jun 2026
13F
Highest disclosed value: $2,564
2 rows are not safely comparable across share classes.
Quick read
EverSource Wealth Advisors, LLC has the largest disclosed position value at $2.6K.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EverSource Wealth Advisors, LLC's linked filing trail.
Disclosed position value
Top 2
EverSource Wealth Advisors, LLC
$2.6K
Bare Financial Services, Inc
$206
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLC |
13F
Company
|
—
class O/S missing
|
$2,564
187 shares
|
— | 30 Jun 2026 |
| Bare Financial Services, Inc |
13F
Company
|
—
class O/S missing
|
$206
15 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 15 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-7 of 7 reporting-owner rows connected to Anbio Biotechnology. Open a relationship link for the CIK-to-CIK filing trail.
Rows
7
Largest Forms 3/4/5 holder
Cany Xu
Net 12M change
$0
Latest report
18 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Cany Xu | Director | Mixed | 18 Mar 2026 | |||
| Chris Tian | Cbo | Mixed | 18 Mar 2026 | |||
| Michael Lau | Ceo | Mixed | 18 Mar 2026 | |||
| Nancy Hartzler | Director | Mixed | 18 Mar 2026 | |||
| Suki Song | Cfo | Mixed | 18 Mar 2026 | |||
| David H. Hsu | Director | Mixed | 18 Mar 2026 | |||
| Michael W.c Zhang | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for Anbio Biotechnology
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.